Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171717 | SCV000055228 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Ambry Genetics | RCV000247905 | SCV000319617 | likely benign | Cardiovascular phenotype | 2018-02-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000340819 | SCV000470249 | uncertain significance | Congenital long QT syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000285908 | SCV000752899 | likely benign | Long QT syndrome | 2023-11-03 | criteria provided, single submitter | clinical testing | |
Dept of Medical Biology, |
RCV000285908 | SCV004022087 | likely benign | Long QT syndrome | 2024-01-08 | criteria provided, single submitter | research | Criteria: BS1, BP4 |
Ce |
RCV000171717 | SCV004164283 | benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | AKAP9: BP4, BS1, BS2 |
Prevention |
RCV003907541 | SCV004721275 | likely benign | AKAP9-related disorder | 2019-06-18 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |